Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China
Yuou Zhang,1 Xuan Liu,1 Linghe Yang,1 Guifang Zhang,2 Zhaoru Gu,3 Zhongdan Chen,4 Jing Sun1 1School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 2Institute of Geriatrics, Beijing Hospital, Beijing, People&r...
Main Authors: | Zhang Y, Liu X, Yang L, Zhang G, Gu Z, Chen Z, Sun J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/barriers-and-strategies-a-review-of-access-to-affordable-multi-drug-re-peer-reviewed-article-IDR |
Similar Items
-
RepTB: a gene ontology based drug repurposing approach for tuberculosis
by: Anurag Passi, et al.
Published: (2018-05-01) -
Prevalence of Multi-Drug Resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa – A High Tuberculosis Endemic Area of Pakistan
by: SAJID ALI, et al.
Published: (2020-01-01) -
Detection of extensively drug resistant pulmonary tuberculosis
by: S.A. Hafez, et al.
Published: (2013-10-01) -
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda
by: Ngabonziza, J.-C.S., et al.
Published: (2020) -
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
by: Giovanni Battista Migliori, et al.
Published: (2017-02-01)